Scott Dalgleish's Insider Trades & SAST Disclosures

Scott Dalgleish's most recent trade in Oncology Institute Inc (The) was a trade of 162,891 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Oncology Institute Inc (The)
Scott Dalgleish Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 162,891 162,891 - - Stock Option (right to buy)
Oncology Institute Inc (The)
Scott Dalgleish Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 350,876 350,876 - - Stock Options (right to buy)
Oncology Institute Inc (The)
Scott Dalgleish Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 261,023 261,023 - - Stock Options (right to buy)
Oncology Institute Inc (The)
Scott Dalgleish Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 71,350 118,916 - 0 Common Stock
Oncology Institute Inc (The)
Scott Dalgleish Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 47,566 47,566 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades